Skip to main content

Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria

The Original Article was published on 22 August 2016

Erratum

After publication of the original article [1], it came to the authors’ attention that in the third paragraph of the ‘Discussion’ section, the value of DAS28 in NEW included patients is indicated wrongly, although correctly cited in Table 2. The correct form of the erroneous sentence is as follows:

“NEW patients´ median disease activity according to the DAS28 before starting bDMARDs is in the lower range in BIOREG compared to other European bDMARD registries (4.46 compared to 4.2–6.6), while median HAQ-DI scores are in a comparable range (1.0 vs 0.8–1.9).”

To correct the original sentence, “(4.46 compared to 4.2–6.6)” should be updated to “(4.13 compared to 4.2–6.6)”, and “in the lower range” should replace “somewhat lower”.

References

  1. Rintelen B, Zwerina J, Herold M, Singer F, Hitzelhammer J, Halder W, et al. Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria. BMC Musculoskelet Disord. 2016;17:358. doi:10.1186/s12891-016-1207-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Bernhard Rintelen.

Additional information

The online version of the original article can be found under doi:10.1186/s12891-016-1207-4.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rintelen, B., Zwerina, J., Herold, M. et al. Erratum to: Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria. BMC Musculoskelet Disord 17, 412 (2016). https://doi.org/10.1186/s12891-016-1270-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12891-016-1270-x